Work

COUNTERPOINT: Should Molecular and Genetic Biomarkers Be Used in the Initial Evaluation of Patients With Fibrotic ILD? No

Year: 2019

Type: article

Source: CHEST Journal

DOI: 10.1016/j.chest.2019.03.027

Author: Brett Ley

Institutions: Kaiser Permanente, University of California, San Francisco, Kaiser Permanente San Francisco Medical Center

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2966585367

FWCI: 0.556

Cites: 21

Cited by: 3

Related to: 10